Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar,…
FILE - As of January 31st, 2023, Humira finally faces competition in the U.S. as the first ... Humira-referenced biosimilar, Amjevita (adalimumab-atto) launches. (AP Photo/David J. Phillip, File)Copyright 2016 The Associated Press. All…